NAFLD, or MAFLD, are asymptomatic, so the combination of serum ALT and AST levels, age, body mass index (BMI), and sex is an important biomarker in the diagnosis of hepatic steatosis [6]. This evidence concerns the gene GPT and fatty liver disease.